Skip to main content

Table 1 Laboratory results for the patient

From: Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case report

  HBsAg Anti-HBc Anti-HBs Anti-HBc IgM HBeAg Anti-HBe HBV DNA ALT (IU/L) AST (IU/L)
March 2012 (pre-immunization) neg. neg. neg.      63 (H) 45 (H)
November 2012 (post-immunization) pos.a neg.a neg.     1.8×109 IU/mL (done a posteriori) (N) (N)
December 2012 pos.a neg.a neg.      56 (H) (N)
January 2013 pos. neg. neg.      (N) (N)
February 2013 pos. neg. neg. neg. pos. neg. 3.5×109 IU/mL (N) (N)
March 2013 pos. neg. neg.   pos. neg. 2.6×109 IU/mL (N) (N)
June 2013 pos. pos. neg.   pos. neg. 2.3×109 IU/mL 53 (H) 54 (H)
October 2013 pos. pos. neg.   pos. neg. 1.8×109 IU/mL 81 (H) 52 (H)
January 2014 pos. pos. pos. (52.7 IU/L)   pos. neg. 5.8×108 IU/mL 65 (H) 44 (H)
April 2014 pos. pos. pos. (133.5 IU/L)   pos. neg. 4.9×108 IU/mL 44 (H) 34 (H)
August 2014 pos. pos. pos. (247.0 IU/L)   pos. neg. 2.9×108 IU/mL 43 (H) 37 (H)
December 2014 (tenofovir started in September 2014) pos. pos. pos. (107.4 IU/L)   pos. neg. 1.6×105 IU/mL (N) (N)
March 2015 pos. pos. pos. (24.3 IU/L)   pos. neg. 5.1×103 IU/mL (N) (N)
June 2015 pos. pos. pos. (27.2 IU/L)   pos. neg. 7.2×102 IU/mL (N) (N)
September 2015 pos. pos. pos. (13.8 IU/L)   pos. neg. 7.1×102 IU/mL (N) (N)
  1. Anti-HBe Hepatitis B envelope antibody, ALT alanine aminotransferase, anti-HBc hepatitis B core antibody, anti-HBs hepatitis B surface antibody, AST aspartate aminotransferase, blank no result available, DNA deoxyribonucleic acid, H elevated value, HBeAg Hepatitis B envelope antigen, HBsAg hepatitis B surface antigen, HBV hepatitis B virus, IgM Immunoglobulin M, IU international units, L Litre, mL Millilitre, N normal value, neg. negative, pos. positive
  2. aConfirmed with a second assay